Healthcare sector | Medical Devices industry
| Price | $19.22 |
|---|---|
| Shares Outstanding | 25.08M |
| All-Time Low | $14.00 |
| 52-Week Low | $15.28 |
| Net Cash / Share | $0 |
|---|---|
| Net Current Assets / Share | $4.05 |
| Net Tangible Assets / Share | $6.64 |
| Shares Outstanding Ave Change (Annual) | 7.17% |
| Shares Δ YoY | 3.59% |
| Avg CA Burn (Annual %) | 24.75% (as of 2-20-2026) |
| Avg CA Burn (Quarterly %) | -0.05% (as of 2-20-2026) |
| Max Earning Power / Share | $-1.81 |
|---|---|
| Adjusted Earning Power |
$-4.47
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
|
| Non-Cash Charges to Market Cap |
1.19%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
|
| Avg EBITDA (5Y) | 0 (as of 2-20-2026) |
| Avg EBITDA (5Q) | 0 (as of 2-20-2026) |
| Avg Net Income (5Y) | -18.4M (as of 2-20-2026) |
| Avg Net Income (5Q) | -10.7M (as of 2-20-2026) |
| Dividend indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 2-20-2026 |
| Consecutive Years Paid | No | 2-20-2026 |
| Pays Dividend | No | 2-20-2026 |
| Income indicators | Value | Date |
|---|---|---|
| EBITDA Positive | No | 2-20-2026 |
| Net Income Positive | No | 2-20-2026 |
| Current Dividend Streak | No | 2-20-2026 |
Pick a metric to view its history table and chart.
Formula: Tangible Book Value / shares from balance statements. Includes 5 quarterly + 4 annual.
Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).
| Report Date | Period | TBV / Share | Tangible Book Value | Shares Used |
|---|---|---|---|---|
| 2025-09-30 | Quarterly | $6.64 | 166.5M ($166,493,000) | 25.1M (25,077,330) |
| 2025-06-30 | Quarterly | $7.04 | 176.5M ($176,463,000) | 25.1M (25,072,502) |
| 2025-03-31 | Quarterly | $7.02 | 174.4M ($174,389,000) | 24.8M (24,827,977) |
| 2024-12-31 | Quarterly | $7.41 | 179.5M ($179,543,000) | 24.2M (24,217,508) |
| 2024-12-31 | Annual | $7.41 | 179.5M ($179,543,000) | 24.2M (24,217,508) |
| 2024-09-30 | Quarterly | $8.05 | 195M ($194,958,000) | 24.2M (24,214,046) |
| 2023-12-31 | Annual | $8.93 | 208.8M ($208,764,000) | 23.4M (23,378,408) |
| 2022-12-31 | Annual | $9.26 | 211.9M ($211,926,000) | 22.9M (22,877,962) |
| 2021-12-31 | Annual | $4.23 | 83.3M ($83,258,000) | 19.7M (19,677,214) |
Revenue from income statements. Includes 4 annual.
Chart plots one annual Revenue point per report date.
| Report Date | Revenue |
|---|---|
| 2024-12-31 | 204.7M ($204,727,000) |
| 2023-12-31 | 148.7M ($148,732,000) |
| 2022-12-31 | 122.3M ($122,289,000) |
| 2021-12-31 | 98M ($98,049,000) |
Historical cash dividends per share from Yahoo ex-dividend dates.
| Date | Dividend / Share |
|---|---|
| No dividend payment history available yet | |
| Date | Shares Outstanding | Delta |
|---|---|---|
| No recent share changes | ||
Latest short-interest change: 931,793 shares (5.50% of float) | Days to cover: 6.57
| Date | Short Interest | Delta | Δ % |
|---|---|---|---|
| 2026-02-27 | 931,793 shares | -59,205 | -5.97% |
| 2026-02-11 | 990,998 shares | -21,298 | -2.10% |
Volume/ratio use shares outstanding as of the event date (frozen).
| Date | Volume | Shares Outstanding | Volume / Shares | Price |
|---|---|---|---|---|
| No interesting volume events | ||||
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.